Great Lakes Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $135M | Sell |
1,069,621
-19,866
| -2% | -$2.62M | 1.03% | 29 |
|
|
2026
Q1 | $152M | Buy |
1,089,487
+67,277
| +7% | +$9.42M | 1.26% | 16 |
|
|
2025
Q4 | $125M | Buy |
1,022,210
+9,394
| +0.9% | +$1.14M | 1.02% | 28 |
|
|
2025
Q3 | $112M | Buy |
1,012,816
+317
| +0% | +$36K | 0.94% | 30 |
|
|
2025
Q2 | $112M | Sell |
1,012,499
-15,537
| -2% | -$1.65M | 0.94% | 24 |
|
|
2025
Q1 | $115M | Buy |
1,028,036
+46,844
| +5% | +$4.83M | 1.03% | 20 |
|
|
2024
Q4 | $90.6M | Buy |
981,192
+482,597
| +97% | +$43.5M | 0.78% | 35 |
|
|
2024
Q3 | $41.8M | Buy |
+498,595
| New | +$38M | 0.35% | 80 |
|
|
2024
Q1 | – | Sell |
-5,270
| Closed | -$427K | – | 826 |
|
|
2023
Q4 | $427K | Sell |
5,270
-119
| -2% | -$9.26K | ﹤0.01% | 625 |
|
|
2023
Q3 | $404K | Sell |
5,389
-1,351
| -20% | -$104K | ﹤0.01% | 621 |
|
|
2023
Q2 | $519K | Sell |
6,740
-80
| -1% | -$6.38K | 0.01% | 592 |
|
|
2023
Q1 | $566K | Buy |
6,820
+288
| +4% | +$23.9K | 0.01% | 627 |
|
|
2022
Q4 | $561K | Buy |
+6,532
| New | +$517K | 0.03% | 489 |
|
|
2022
Q3 | – | Sell |
-49,444
| Closed | -$3.06M | – | 665 |
|
|
2022
Q2 | $3.06M | Sell |
49,444
-1,624
| -3% | -$101K | 0.06% | 300 |
|
|
2022
Q1 | $3.04M | Buy |
+51,068
| New | +$3.26M | 0.05% | 330 |
|
|
2020
Q1 | – | Sell |
-3,352
| Closed | -$218K | – | 550 |
|
|
2019
Q4 | $218K | Buy |
+3,352
| New | +$218K | ﹤0.01% | 534 |
|
|
2018
Q3 | – | Sell |
-13,939
| Closed | -$987K | – | 622 |
|
|
2018
Q2 | $987K | Sell |
13,939
-16,681
| -54% | -$1.18M | 0.02% | 384 |
|
|
2018
Q1 | $2.31M | Sell |
30,620
-42,699
| -58% | -$3.39M | 0.06% | 295 |
|
|
2017
Q4 | $5.25M | Buy |
73,319
+2,015
| +3% | +$153K | 0.12% | 161 |
|
|
2017
Q3 | $5.78M | Buy |
71,304
+25,965
| +57% | +$1.99M | 0.14% | 139 |
|
|
2017
Q2 | $3.21M | Sell |
45,339
-11,594
| -20% | -$772K | 0.08% | 214 |
|
|
2017
Q1 | $3.87M | Sell |
56,933
-5,451
| -9% | -$383K | 0.1% | 185 |
|
|
2016
Q4 | $4.47M | Buy |
62,384
+238
| +0.4% | +$17.7K | 0.12% | 148 |
|
|
2016
Q3 | $4.92M | Sell |
62,146
-1,042
| -2% | -$84.6K | 0.13% | 122 |
|
|
2016
Q2 | $5.27M | Sell |
63,188
-2,209
| -3% | -$196K | 0.14% | 121 |
|
|
2016
Q1 | $6.01M | Buy |
65,397
+12,435
| +23% | +$1.12M | 0.16% | 109 |
|
|
2015
Q4 | $5.36M | Buy |
52,962
+2,124
| +4% | +$221K | 0.16% | 110 |
|
|
2015
Q3 | $4.99M | Sell |
50,838
-8,251
| -14% | -$916K | 0.15% | 103 |
|
|
2015
Q2 | $6.92M | Buy |
59,089
+1,624
| +3% | +$177K | 0.21% | 80 |
|
|
2015
Q1 | $5.64M | Sell |
57,465
-34,179
| -37% | -$3.47M | 0.17% | 96 |
|
|
2014
Q4 | $8.64M | Buy |
91,644
+17,382
| +23% | +$1.8M | 0.27% | 72 |
|
|
2014
Q3 | $7.91M | Buy |
74,262
+27,835
| +60% | +$2.73M | 0.27% | 72 |
|
|
2014
Q2 | $3.85M | Sell |
46,427
-4,130
| -8% | -$321K | 0.16% | 77 |
|
|
2014
Q1 | $3.58M | Buy |
50,557
+9,493
| +23% | +$745K | 0.16% | 80 |
|
|
2013
Q4 | $3.08M | Buy |
41,064
+1,605
| +4% | +$112K | 0.14% | 76 |
|
|
2013
Q3 | $2.48M | Buy |
39,459
+31,634
| +404% | +$1.89M | 0.11% | 102 |
|
|
2013
Q2 | $401K | Buy |
+7,825
| New | +$408K | 0.02% | 263 |
|
Other funds holding GILD
Great Lakes Advisors's GILD Position: Q2 2026 in Review
Great Lakes Advisors reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $2.62M and leaving 1,069,621 shares worth $135M. The position accounts for 1.03% of the portfolio, ranked #29.
Great Lakes Advisors first reported a position in GILD in Q2 2013 and has held it in 37 quarters since. The position peaked at $152M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Great Lakes Advisors held 1,069,621 shares of Gilead Sciences worth $135M as of Q2 2026.
- Great Lakes Advisors sold 19,866 Gilead Sciences shares in Q2 2026, an estimated $2.62M.
- Gilead Sciences made up 1.03% of Great Lakes Advisors's portfolio in Q2 2026, its #29 holding.
- Great Lakes Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 37 quarters since.
- Great Lakes Advisors's Gilead Sciences position peaked at $152M in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.